Nuwellis Past Earnings Performance

Past criteria checks 0/6

Nuwellis has been growing earnings at an average annual rate of 1.9%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 9% per year.

Key information

1.9%

Earnings growth rate

84.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.0%
Return on equityn/a
Net Margin-253.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nuwellis makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:22S Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 249-23154
31 Mar 249-20165
31 Dec 239-23175
30 Sep 239-17185
30 Jun 238-17195
31 Mar 238-17195
31 Dec 229-15184
30 Sep 228-17174
30 Jun 228-18175
31 Mar 228-19185
31 Dec 218-20195
30 Sep 218-18195
30 Jun 218-17194
31 Mar 218-17184
31 Dec 207-18174
30 Sep 207-19174
30 Jun 206-19174
31 Mar 206-20174
31 Dec 196-23165
30 Sep 196-22165
30 Jun 196-22165
31 Mar 195-22154
31 Dec 185-17153
30 Sep 184-29143
30 Jun 184-27132
31 Mar 184-27122
31 Dec 174-25101
30 Sep 173-14102
30 Jun 173-1593
31 Mar 172-1685
31 Dec 161-1878
30 Sep 161-19712
30 Jun 160-22715
31 Mar 160-24816
31 Dec 150-27818
30 Sep 150-27918
30 Jun 150-26917
31 Mar 150-26918
31 Dec 140-26917
30 Sep 140-261016
30 Jun 140-261016
31 Mar 140-241015
31 Dec 130-22914
30 Sep 130-19812

Quality Earnings: 22S is currently unprofitable.

Growing Profit Margin: 22S is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 22S is unprofitable, but has reduced losses over the past 5 years at a rate of 1.9% per year.

Accelerating Growth: Unable to compare 22S's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 22S is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: 22S's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/24 16:28
End of Day Share Price 2024/06/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nuwellis, Inc. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jan WaldBenchmark Company
Sean LavinBTIG
Jason MillsCanaccord Genuity